from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0544c/-

LFCtreatmentdescriptionclass of inhibitor

-1.503

Amikacinug/mL Amikacintranslation

-0.996

Cap5-10ug/mL Capreomycintranslation

0.224

Rox10-50 ug/mL Roxithromycintranslation

0.224

SM2-5 ug/mL Streptomycintranslation

-2.564

Tet5-10 ug/mL Tetracyclinetranslation

-0.347

Rif0.2-5ug/mL Rifampicintranscription

0.139

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.776

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.688

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.340

CPZ10-50 ug/mL Chlorpromazinerespiration

1.395

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.144

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.277

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.604

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.011

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.036

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.193

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.626

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.618

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.055

KCN5-20 ug/mL Potassium cyaniderespiration

-0.838

NaN30.2-2 mM Sodium aziderespiration

0.317

Nigericin50 uM Nigericinrespiration

-0.772

TRC10-150 ug/mL Triclosanrespiration

0.149

TRZ10-25 ug/mL Thioridazinerespiration

-1.965

Valinomycin0.5-10 uM Valinomycinrespiration

-0.281

ZnSO42 mM ZnSO4respiration

-1.238

menadione6-10 ug/mL Menadionerespiration

-0.208

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.106

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.345

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.478

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.559

NRP_1Non-replicating persistence stage 1dosRassociated

0.480

Amp0.2mg/mL AmpicillincellWall

1.168

Cephalexin20-100 ug/mL CephalexincellWall

0.143

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.392

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.004

EMB10-20 ug/mL EthambutolcellWall

0.148

Eta12-40 ug/mL EthionamidecellWall

0.166

INH0.2-0.4 ug/mL IsoniazidcellWall

0.349

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.487

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.734

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.060

BZA0.12 mg/mL BenzamidearomaticAmides

0.128

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.117

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.353

H2O24 mM hydrogen peroxideDNAdamaging

-0.049

Levo10 ug/mL LevofloxacinDNAdamaging

0.675

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.093

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.021

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.722

UVUV-irradiationDNAdamaging

0.744

ARP41-4 ug/mL Antitubercular compound ARP4?

0.464

Antimycin12.5-50 ug/mL Antimycin A?

-0.632

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.631

PA_110-50 ug/mL Antitubercular compound PA-1?

0.408

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.927

PA8240.2-2 ug/mL PA-824?

-0.659

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.054

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.420

Verapamil50 uM Verapamil?

0.173

mercaptoethanol2 mM 2-Mercaptoethanol?

0.146

methoxatin10-20 ug/mL Methoxatin?